| 000 | 01736 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250517112059.0 | ||
| 264 | 0 | _c20180105 | |
| 008 | 201801s 0 0 eng d | ||
| 022 | _a1740-634X | ||
| 024 | 7 |
_a10.1038/npp.2016.154 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aD'Amico, Davide | |
| 245 | 0 | 0 |
_aInfralimbic Neurotrophin-3 Infusion Rescues Fear Extinction Impairment in a Mouse Model of Pathological Fear. _h[electronic resource] |
| 260 |
_bNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology _c01 2017 |
||
| 300 |
_a462-472 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 |
_aExtinction, Psychological _xdrug effects |
| 650 | 0 | 4 |
_aExtracellular Signal-Regulated MAP Kinases _xmetabolism |
| 650 | 0 | 4 | _aFear |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aLong-Term Potentiation |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMice, Inbred C57BL |
| 650 | 0 | 4 | _aMice, Transgenic |
| 650 | 0 | 4 | _aNeuronal Plasticity |
| 650 | 0 | 4 |
_aNeurotrophin 3 _xadministration & dosage |
| 650 | 0 | 4 |
_aPhobic Disorders _xphysiopathology |
| 650 | 0 | 4 |
_aPrefrontal Cortex _xdrug effects |
| 650 | 0 | 4 |
_aPyramidal Cells _xdrug effects |
| 650 | 0 | 4 |
_aReceptor, trkC _xagonists |
| 700 | 1 | _aGener, Thomas | |
| 700 | 1 | _ade Lagrán, Maria Martínez | |
| 700 | 1 | _aSanchez-Vives, Maria V | |
| 700 | 1 | _aSantos, Mónica | |
| 700 | 1 | _aDierssen, Mara | |
| 773 | 0 |
_tNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology _gvol. 42 _gno. 2 _gp. 462-472 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/npp.2016.154 _zAvailable from publisher's website |
| 999 |
_c26336727 _d26336727 |
||